Other NAFLD-related gene variants, such as LYPLAL1 and MBOAT7, showed no increase in the risk of diabetes (Dongiovanni et al., 2018; Sliz et al., 2018). This evidence concerns the gene LYPLAL1 and metabolic dysfunction-associated steatotic liver disease.